IGHG3 and COVID-19: Moreover, the lack of superior RBD-specific IgG3 responses in COVID-19 recovered individuals is in agreement with earlier findings that reported a low frequency of SARS-CoV-2 memory B cells expressing IgG3 in COVID-19 convalescent individuals (19).